No Benefit From Increased Folate, Vitamin B6 for Parkinson Disease Risk
Researchers sought to examine the association of long-term intake of folate, vitamin B6, and vitamin B12 with Parkinson disease risk.
Diagnosis & Disease Information
Distressing Dreams in Childhood May Predict Future Cognitive Impairment, Parkinson Disease
Researchers sought to assess the association between distressing dreams in childhood and the risk of developing cognitive impairment or Parkinson disease by age 50.
FDA Requests Device Info for Novel Parkinson Disease Infusion Therapy
ABBV-951 is a solution of levodopa and carbidopa prodrugs for continuous subcutaneous delivery.
Common Viruses May Increase Long-Term Risk for Neurodegenerative Diseases
Researchers sought to examine potential associations between viral exposures and neurodegenerative disease risk.
Vitamin D Deficiency Linked to Neurologic Disorders
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
FDA Needs More Data Before Deciding on Apomorphine Infusion Device
SPN-830 provides a continuous subutaneous infusion of apomorphine through an infusion pump
Circulating MicroRNAs as Potential Biomarkers for Parkinson Disease Diagnosis
In a meta-analysis, researchers evaluated the diagnostic accuracy of circulating miRNAs in the diagnosis of PD.
Supernus One Step Closer to Decision on Apomorphine Infusion Device
SPN-830 provides a continuous subcutaneous infusion of apomorphine through an infusion pump.
Amyotrophic Lateral Sclerosis Prevention: Neurodegenerative Diseases Offer Insight
Researchers sought to develop a “roadmap” to early intervention and disease prevention for ALS by observing advances in neurodegenerative diseases with a presymptomatic period.
Novel Pramipexole-Rasagiline Combo Promising for Early Parkinson Disease
The fixed-dose combination therapy was found to be superior to each component.
- Loading...
Loading...
Next post in News
Loading... 
Loading...